Authors' Reply to Mungmunpuntipantip et al.'s Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands".
Agnes C KantFlorence P A M van HunselPublished in: Drug safety (2022)